Hannah Valantine
CIK 1855608 · View on SEC EDGAR ↗
Insider
First SEC filing: Feb. 13, 2024 · Latest: June 16, 2026
On this page
Insider at
Insider transactions
0 buys (P)
5 sells (S)
Net:
$-1,661,338
+ 50 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
50 other filings hidden
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 16, 2026 | CDNA | S 10b5-1 | 100 | $36.55 | $3,655 | 36,686 Direct | -0.27% | Disposed | 29.3% (price as of 2026-08-20) |
| July 16, 2026 | CDNA | S 10b5-1 | 28,679 | $36.14 | $1,036,459 | 36,786 Direct | -43.81% | Disposed | 30.7% (price as of 2026-08-20) |
| June 23, 2026 | BBIO | S 10b5-1 | 2,196 | $68.57 | $150,580 | 9,259 Direct | -19.17% | Disposed | 21.4% (price as of 2026-08-20) |
| June 22, 2026 | BBIO | S 10b5-1 | 2,808 | $68.00 | $190,944 | 11,455 Direct | -19.69% | Disposed | 22.4% (price as of 2026-08-20) |
| June 15, 2026 | CDNA | S 10b5-1 | 12,103 | $23.11 | $279,700 | 36,686 Direct | -24.81% | Disposed | 104.5% (price as of 2026-08-20) |
| June 26, 2025 | BBIO | S | 1,891 | $44.03 | $83,261 | 398 Indirect | -82.61% | Disposed | 89.1% (price as of 2026-08-20) |
| June 26, 2025 | BBIO | S | 398 | $44.13 | $17,564 | 2,289 Indirect | -14.81% | Disposed | 88.7% (price as of 2026-08-20) |
| June 26, 2025 | BBIO | S | 1,542 | $44.01 | $67,863 | 7,465 Direct | -17.12% | Disposed | 89.2% (price as of 2026-08-20) |
| June 26, 2025 | BBIO | S | 876 | $44.11 | $38,640 | 9,007 Direct | -8.86% | Disposed | 88.7% (price as of 2026-08-20) |
| June 18, 2025 | CDNA | S 10b5-1 | 10,570 | $19.16 | $202,521 | 38,994 Direct | -21.33% | Disposed | 146.6% (price as of 2026-08-20) |
| June 10, 2025 | BBIO | S 10b5-1 | 4,292 | $40.00 | $171,680 | 1,764 Direct | -70.87% | Disposed | 108.1% (price as of 2026-08-20) |
| March 6, 2025 | BBIO | S 10b5-1 | 12,875 | $32.58 | $419,468 | 1,764 Direct | -87.95% | Disposed | 155.5% (price as of 2026-08-20) |
| Feb. 15, 2024 | BBIO | S 10b5-1 | 2,915 | $37.75 | $110,041 | 1,764 Direct | -62.30% | Disposed | 120.5% (price as of 2026-08-20) |
| Jan. 16, 2024 | BBIO | S 10b5-1 | 2,915 | $37.97 | $110,683 | 1,764 Direct | -62.30% | Disposed | 119.3% (price as of 2026-08-20) |
| Dec. 15, 2023 | BBIO | S 10b5-1 | 2,915 | $36.12 | $105,290 | 1,764 Direct | -62.30% | Disposed | 130.5% (price as of 2026-08-20) |
| Nov. 15, 2023 | BBIO | S 10b5-1 | 2,915 | $30.00 | $87,450 | 1,764 Direct | -62.30% | Disposed | 177.5% (price as of 2026-08-20) |
| Dec. 29, 2021 | BBIO | P | 1,752 | $14.24 | $24,948 | 3,294 Direct | +113.62% | Acquired | 484.7% (price as of 2026-08-20) |
| Dec. 29, 2021 | BBIO | P | 1,764 | $14.23 | $25,102 | 1,764 Direct | — | Acquired | 485.1% (price as of 2026-08-20) |
| Dec. 28, 2021 | BBIO | P | 796 | $13.16 | $10,475 | 2,687 Indirect | +42.09% | Acquired | 532.6% (price as of 2026-08-20) |
| Dec. 28, 2021 | BBIO | P | 1,542 | $12.68 | $19,553 | 1,542 Direct | — | Acquired | 556.6% (price as of 2026-08-20) |
| Dec. 28, 2021 | BBIO | P | 1,542 | $12.68 | $19,553 | 3,433 Indirect | +81.54% | Acquired | 556.6% (price as of 2026-08-20) |
| Dec. 28, 2021 | BBIO | P | 1,891 | $13.18 | $24,923 | 1,891 Indirect | — | Acquired | 531.7% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 16, 2026 | CDNA | Stock Option (Right to Buy) | Common Stock (5,125) | $7.96 | June 15, 2033 | 5,125 | Disposed |
| July 16, 2026 | CDNA | Stock Option (Right to Buy) | Common Stock (16,048) | $14.19 | June 13, 2034 | 16,048 | Disposed |
| July 16, 2026 | CDNA | Stock Option (Right to Buy) | Common Stock (7,606) | $20.56 | June 15, 2032 | 7,606 | Disposed |
| June 22, 2026 | BBIO | Stock Option (Right to Buy) | Common Stock (2,808) | $41.73 | June 19, 2035 | 2,808 | Disposed |
| June 22, 2026 | BBIO | Stock Option (Right to Buy) | Common Stock (5,277) | $68.92 | June 21, 2036 | 5,277 | Acquired |
| June 3, 2026 | PACB | Stock Option (right to buy) | Common Stock (223,492) | $1.58 | June 3, 2036 | 223,492 | Acquired |
| June 20, 2025 | BBIO | Stock Option (Right to Buy) | Common Stock (8,425) | $41.73 | June 19, 2035 | 8,425 | Acquired |
| June 10, 2025 | BBIO | Stock Option (right to buy) | Common Stock (4,292) | $16.75 | June 21, 2033 | 4,292 | Disposed |
| June 4, 2025 | PACB | Stock Option (right to buy) | Common Stock (65,000) | $1.03 | June 4, 2035 | 65,000 | Acquired |
| March 6, 2025 | BBIO | Stock Option (right to buy) | Common Stock (12,875) | $16.75 | June 21, 2033 | 12,875 | Disposed |
| June 21, 2024 | BBIO | Stock Option (Right to Buy) | Common Stock (26,014) | $27.36 | June 20, 2034 | 26,014 | Acquired |
| June 18, 2024 | PACB | Stock Option (right to buy) | Common Stock (32,179) | $1.65 | June 18, 2034 | 32,179 | Acquired |
| June 14, 2024 | CDNA | Stock Option (right to buy) | Common Stock (16,048) | — | June 14, 2034 | 16,048 | Acquired |
| June 14, 2024 | CDNA | Stock Option (right to buy) | Common Stock (16,048) | $9.35 | June 14, 2034 | 16,048 | Acquired |
| Feb. 15, 2024 | BBIO | Stock Option (right to buy) | Common Stock (2,915) | $8.45 | June 22, 2032 | 2,915 | Disposed |
| Jan. 16, 2024 | BBIO | Stock Option (right to buy) | Common Stock (2,915) | $8.45 | June 22, 2032 | 2,915 | Disposed |
| Dec. 15, 2023 | BBIO | Stock Option (right to buy) | Common Stock (2,915) | $8.45 | June 22, 2032 | 2,915 | Disposed |
| Nov. 15, 2023 | BBIO | Stock Option (right to buy) | Common Stock (2,915) | $8.45 | June 22, 2032 | 2,915 | Disposed |
| June 21, 2023 | BBIO | Stock Option (right to buy) | Common Stock (51,501) | $16.75 | June 21, 2033 | 51,501 | Acquired |
| June 16, 2023 | CDNA | Common Stock | Common Stock (29,136) | $7.96 | June 16, 2033 | 29,136 | Acquired |
| May 24, 2023 | PACB | Stock Option (right to buy) | Common Stock (25,775) | $11.94 | May 24, 2033 | 25,775 | Acquired |
| June 22, 2022 | BBIO | Stock Option (right to buy) | Common Stock (104,921) | $8.45 | June 22, 2032 | 104,921 | Acquired |
| June 16, 2022 | CDNA | Common Stock | Common Stock (7,606) | $20.56 | June 16, 2032 | 7,606 | Acquired |
| May 25, 2022 | PACB | Stock Option (right to buy) | Common Stock (63,015) | $5.37 | May 25, 2032 | 63,015 | Acquired |
| Oct. 25, 2021 | BBIO | Stock Option (right to buy) | Common Stock (50,968) | $48.45 | Oct. 24, 2031 | 50,968 | Acquired |
| July 1, 2021 | CDNA | Employee Stock Option (right to buy) | Common Stock (1,630) | $91.99 | July 1, 2031 | 1,630 | Acquired |
| June 16, 2021 | PACB | Stock Option (right to buy) | Common Stock (28,992) | $27.90 | June 16, 2031 | 28,992 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).